Investment Analysts’ Price Target Changes for November 5th (ADNT, ADUS, AMPL, ARCB, ASH, BAM, CAR, CDW, CHYM, CLOV)

Investment Analysts’ price target changes for Thursday, November 5th:

Adient (NYSE:ADNT) had its price target cut by JPMorgan Chase & Co. from $25.00 to $23.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Addus HomeCare (NASDAQ:ADUS) had its target price boosted by UBS Group from $145.00 to $160.00. The firm currently has a buy rating on the stock.

Amplitude (NASDAQ:AMPL) had its target price increased by UBS Group from $13.00 to $22.00. They currently have a buy rating on the stock.

ArcBest (NASDAQ:ARCB) had its target price boosted by JPMorgan Chase & Co. from $158.00 to $164.00. They currently have a neutral rating on the stock.

Ashland (NYSE:ASH) had its price target increased by JPMorgan Chase & Co. from $80.00 to $82.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Brookfield Asset Management (NYSE:BAM) (TSE:BAM.A) had its target price increased by JPMorgan Chase & Co. from $55.00 to $58.00. The firm currently has a neutral rating on the stock.

Avis Budget Group (NASDAQ:CAR) had its target price cut by JPMorgan Chase & Co. from $105.00 to $85.00. The firm currently has an underweight rating on the stock.

CDW (NASDAQ:CDW) had its price target raised by JPMorgan Chase & Co. from $170.00 to $195.00. The firm currently has an overweight rating on the stock.

CDW (NASDAQ:CDW) had its price target increased by UBS Group from $159.00 to $195.00. They currently have a buy rating on the stock.

Chime Financial (NASDAQ:CHYM) had its price target increased by UBS Group from $31.00 to $34.00. UBS Group currently has a neutral rating on the stock.

Chime Financial (NASDAQ:CHYM) had its target price raised by JPMorgan Chase & Co. from $35.00 to $40.00. They currently have an overweight rating on the stock.

Clover Health Investments (NASDAQ:CLOV) had its price target raised by UBS Group from $5.00 to $5.50. UBS Group currently has a neutral rating on the stock.

Costco Wholesale (NASDAQ:COST) had its price target raised by JPMorgan Chase & Co. from $1,015.00 to $1,150.00. The firm currently has an overweight rating on the stock.

Corpay (NYSE:CPAY) had its price target boosted by UBS Group from $415.00 to $465.00. They currently have a neutral rating on the stock.

Charles River Laboratories International (NYSE:CRL) had its target price boosted by UBS Group from $357.00 to $387.00. The firm currently has a buy rating on the stock.

Dave (NASDAQ:DAVE) had its price target cut by JPMorgan Chase & Co. from $480.00 to $435.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

e.l.f. Beauty (NYSE:ELF) had its target price increased by JPMorgan Chase & Co. from $130.00 to $135.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Edwards Lifesciences (NYSE:EW) had its price target raised by UBS Group from $110.00 to $118.00. UBS Group currently has a buy rating on the stock.

Freshpet (NASDAQ:FRPT) had its price target increased by JPMorgan Chase & Co. from $76.00 to $78.00. They currently have an overweight rating on the stock.

GlobalFoundries (NASDAQ:GFS) had its target price reduced by JPMorgan Chase & Co. from $57.00 to $50.00. They currently have a neutral rating on the stock.

GXO Logistics (NYSE:GXO) had its price target raised by UBS Group from $64.00 to $69.00. They currently have a buy rating on the stock.

Hamilton Lane (NASDAQ:HLNE) had its price target increased by UBS Group from $115.00 to $120.00. UBS Group currently has a buy rating on the stock.

HubSpot (NYSE:HUBS) had its target price trimmed by UBS Group from $310.00 to $240.00. UBS Group currently has a neutral rating on the stock.

International Flavors & Fragrances (NYSE:IFF) had its target price raised by JPMorgan Chase & Co. from $92.00 to $95.00. They currently have an overweight rating on the stock.

International Flavors & Fragrances (NYSE:IFF) had its target price raised by UBS Group from $91.00 to $95.00. UBS Group currently has a neutral rating on the stock.

Jack Henry & Associates (NASDAQ:JKHY) had its target price raised by UBS Group from $170.00 to $185.00. UBS Group currently has a neutral rating on the stock.

Kennametal (NYSE:KMT) had its target price lowered by JPMorgan Chase & Co. from $30.00 to $27.00. The firm currently has an underweight rating on the stock.

Limbach (NASDAQ:LMB) had its price target raised by JPMorgan Chase & Co. from $50.00 to $55.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.

LegalZoom.com (NASDAQ:LZ) had its price target reduced by JPMorgan Chase & Co. from $7.00 to $6.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Medline (NASDAQ:MDLN) had its price target boosted by UBS Group from $43.00 to $49.00. The firm currently has a buy rating on the stock.

Marqeta (NASDAQ:MQ) had its price target increased by UBS Group from $19.00 to $21.00. They currently have a neutral rating on the stock.

Madison Square Garden Entertainment (NYSE:MSGE) had its target price boosted by JPMorgan Chase & Co. from $83.00 to $84.00. They currently have a neutral rating on the stock.

Motorola Solutions (NYSE:MSI) had its target price increased by UBS Group from $520.00 to $570.00. They currently have a buy rating on the stock.

Navient (NASDAQ:NAVI) had its price target raised by JPMorgan Chase & Co. from $8.50 to $9.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Envista (NYSE:NVST) had its target price boosted by UBS Group from $27.00 to $29.00. UBS Group currently has a neutral rating on the stock.

Paycom Software (NYSE:PAYC) had its price target raised by JPMorgan Chase & Co. from $264.00 to $265.00. The firm currently has a neutral rating on the stock.

Phillips Edison & Company, Inc. (NASDAQ:PECO) had its target price boosted by JPMorgan Chase & Co. from $41.00 to $43.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Insulet (NASDAQ:PODD) had its target price increased by JPMorgan Chase & Co. from $152.00 to $170.00. The firm currently has a neutral rating on the stock.

People Incorporated Common Stock (NASDAQ:PPLI) had its price target reduced by UBS Group from $56.00 to $45.00. UBS Group currently has a neutral rating on the stock.

Qualcomm (NASDAQ:QCOM) had its price target trimmed by UBS Group from $185.00 to $180.00. The firm currently has a neutral rating on the stock.

Ridgepost Capital (NYSE:RPC) had its price target raised by JPMorgan Chase & Co. from $14.00 to $15.00. The firm currently has an overweight rating on the stock.

SharkNinja (NYSE:SN) had its target price increased by JPMorgan Chase & Co. from $223.00 to $243.00. They currently have an overweight rating on the stock.

Seaport Therapeutics (NASDAQ:SPTX) had its target price boosted by JPMorgan Chase & Co. from $40.00 to $41.00. The firm currently has an overweight rating on the stock.

Trimble (NASDAQ:TRMB) had its target price reduced by JPMorgan Chase & Co. from $75.00 to $73.00. They currently have an overweight rating on the stock.

Marriott Vacations Worldwide (NYSE:VAC) had its price target reduced by JPMorgan Chase & Co. from $125.00 to $124.00. They currently have an overweight rating on the stock.

Zimmer Biomet (NYSE:ZBH) had its target price raised by JPMorgan Chase & Co. from $117.00 to $120.00. They currently have a neutral rating on the stock.